S&S Healthcare Holding Ltd. (TPEX:4198)
Taiwan · Delayed Price · Currency is TWD 35.80
+0.70 (1.99%)
Feb 11, 2026, 1:20 PM CST
S&S Healthcare Holding Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 205.64 | 240.25 | 254.52 | 254.44 | 122.35 | 101.36 | |
Revenue Growth (YoY) | -18.48% | -5.61% | 0.03% | 107.95% | 20.71% | -44.22% |
Cost of Revenue | 142.93 | 165.24 | 218.87 | 216.05 | 130.29 | 124.76 |
Gross Profit | 62.71 | 75.01 | 35.66 | 38.39 | -7.93 | -23.4 |
Selling, General & Admin | 109.81 | 133.38 | 111.9 | 113.92 | 71.61 | 73.48 |
Research & Development | 9.16 | 10.04 | 15.11 | 21.38 | 24.33 | 36.17 |
Operating Expenses | 118.32 | 142.99 | 128.58 | 148.91 | 95.36 | 110.98 |
Operating Income | -55.61 | -67.98 | -92.92 | -110.52 | -103.29 | -134.38 |
Interest Expense | -1.29 | -2.17 | -5.24 | -2.37 | -1.74 | -1.92 |
Interest & Investment Income | 1.69 | 1.45 | 0.99 | 0.45 | 0.46 | 0.28 |
Earnings From Equity Investments | -4.65 | 0.09 | - | - | - | - |
Currency Exchange Gain (Loss) | 0.28 | 1.54 | 1.33 | 4.57 | -0.78 | -0.3 |
Other Non Operating Income (Expenses) | 8.17 | 8.66 | 15.06 | 33.43 | 9.99 | 22.45 |
EBT Excluding Unusual Items | -51.41 | -58.41 | -80.79 | -74.44 | -95.34 | -113.87 |
Gain (Loss) on Sale of Investments | 1.14 | - | - | - | - | - |
Gain (Loss) on Sale of Assets | 12.08 | 12.08 | 186.58 | 4.07 | -0.05 | -0.94 |
Asset Writedown | - | - | -3.15 | - | - | - |
Other Unusual Items | - | - | 0.21 | - | - | - |
Pretax Income | -38.19 | -46.33 | 102.86 | -70.37 | -95.39 | -114.82 |
Income Tax Expense | 2.21 | 2.16 | -0.03 | -1.21 | - | 0.05 |
Earnings From Continuing Operations | -40.4 | -48.49 | 102.89 | -69.16 | -95.39 | -114.87 |
Minority Interest in Earnings | 6.52 | 7.22 | 0.72 | 2.27 | - | - |
Net Income | -33.88 | -41.28 | 103.61 | -66.89 | -95.39 | -114.87 |
Net Income to Common | -33.88 | -41.28 | 103.61 | -66.89 | -95.39 | -114.87 |
Shares Outstanding (Basic) | 24 | 24 | 23 | 18 | 15 | 12 |
Shares Outstanding (Diluted) | 24 | 24 | 23 | 18 | 15 | 12 |
Shares Change (YoY) | -0.01% | 4.56% | 30.09% | 21.08% | 18.96% | 44.61% |
EPS (Basic) | -1.41 | -1.71 | 4.49 | -3.77 | -6.52 | -9.34 |
EPS (Diluted) | -1.41 | -1.71 | 4.49 | -3.77 | -6.52 | -9.34 |
Free Cash Flow | -7.11 | -67.88 | -98.7 | -89.07 | -80.04 | -68.17 |
Free Cash Flow Per Share | -0.29 | -2.82 | -4.28 | -5.03 | -5.47 | -5.54 |
Gross Margin | 30.50% | 31.22% | 14.01% | 15.09% | -6.48% | -23.09% |
Operating Margin | -27.04% | -28.30% | -36.51% | -43.44% | -84.42% | -132.58% |
Profit Margin | -16.48% | -17.18% | 40.71% | -26.29% | -77.97% | -113.32% |
Free Cash Flow Margin | -3.46% | -28.26% | -38.78% | -35.01% | -65.42% | -67.25% |
EBITDA | -42.22 | -48.63 | -71.88 | -81.63 | -88.93 | -123.74 |
EBITDA Margin | -20.53% | -20.24% | -28.24% | -32.08% | -72.69% | -122.08% |
D&A For EBITDA | 13.39 | 19.35 | 21.04 | 28.88 | 14.35 | 10.64 |
EBIT | -55.61 | -67.98 | -92.92 | -110.52 | -103.29 | -134.38 |
EBIT Margin | -27.04% | -28.30% | -36.51% | -43.44% | -84.42% | -132.58% |
Advertising Expenses | - | 2.92 | 3.92 | 4.29 | 1.33 | 2.6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.